Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Hepatocellular Carcinoma · Stage III Hepatocellular Carcinoma AJCC v8 · Stage IIIA Hepatocellular Carcinoma AJCC v8 · Stage IIIB Hepatocellular Carcinoma AJCC v8 · Stage IV Hepatocellular Carcinoma AJCC v8 · Stage IVA Hepatocellular Carcinoma AJCC v8 · Stage IVB Hepatocellular Carcinoma AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (Luchia Andemicael) · Luchia.Andemicael@ucsf.edu
Study coordinator · cancertrials@ucsf.edu · 877-827-3222
Contact: Principal Investigator (Mary Feng, MD)

Study leads

Mary Feng, MD
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

Hepatocellular Carcinoma · Cirrhosis, Liver

Abroad (travel likely)RecruitingPHASE2

San Antonio, United States

Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab

Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1

San Diego, United States

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Solid Tumors · Non-small Cell Lung Cancer · Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bengbu, China · Beijing, China

A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States